uPA-mediated plasminogen activation is enhanced by polyphosphate

Tissue plasminogen activator (tPA) and urokinase plasminogen activator (uPA) differ in their modes of action. Efficient tPA-mediated plasminogen activation requires binding to fibrin. In contrast, uPA is fibrin independent and activates plasminogen in solution or when associated with its cellular receptor urokinase protease activated receptor (uPAR). We have previously shown that polyphosphate (polyP), alters fibrin structure and attenuates tPA and plasminogen binding to fibrin, thereby down-regulating fibrinolysis. Here we investigate the impact of polyP on uPA-mediated fibrinolysis. As previously reported polyP of an average chain length of 65 (polyP65) delays tPA-mediated fibrinolysis. The rate of plasmin generation was also delayed and reduced 1.6-fold in polyP65 -containing clots (0.74±0.06 vs. 1.17±0.14 pM/s in P<0.05). Analysis of tPA-mediated fibrinolysis in real-time by confocal microscopy was significantly slower in polyP65 -containing clots. In marked contrast, polyP65 augmented the rate of uPA-mediated plasmin generation 4.7-fold (3.96±0.34 vs. 0.84±0.08 pM/s; P<0.001) and acce-lerated fibrinolysis (t1/2 64.5±1.7 min vs. 108.2±3.8 min; P<0.001). Analysis of lysis in real-time confirmed that polyP65 enhanced uPA-mediated fibrino- lysis. Varying the plasminogen concentration (0.125-1 mM) in clots dose-dependently enhanced uPA-mediated fibrinolysis, while negligible changes were observed on tPA-mediated fibrinolysis. The accelerating effect of polyP65 on uPA-mediated fibrinolysis was overcome by additional plasminogen, while the down-regulation of tPA-mediated lysis and plasmin generation was largely unaffected. polyP65 exerts opposing effects on tPA- and uPA-mediated fibrinolysis, attenuating the fibrin cofactor function in tPA-media-ted plasminogen activation. In contrast, polyP may facilitate the interaction between fibrin-independent uPA and plasminogen thereby accelerating plasmin generation and downstream fibrinolysis.

[1]  T. Renné,et al.  Polyphosphate nanoparticles on the platelet surface trigger contact system activation. , 2017, Blood.

[2]  A. S. Lionikiene,et al.  Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity. , 2016, Blood.

[3]  Marco M. Domingues,et al.  Polyphosphate Delays Fibrin Polymerisation and Alters the Mechanical Properties of the Fibrin Network , 2016, Thrombosis and Haemostasis.

[4]  S. Diamond,et al.  A systems approach to hemostasis: 2. Computational analysis of molecular transport in the thrombus microenvironment. , 2014, Blood.

[5]  S. Diamond,et al.  A systems approach to hemostasis: 3. Thrombus consolidation regulates intrathrombus solute transport and local thrombin activity. , 2014, Blood.

[6]  S. Diamond,et al.  A systems approach to hemostasis: 1. The interdependence of thrombus architecture and agonist movements in the gaps between platelets. , 2014, Blood.

[7]  A. S. Lionikiene,et al.  Single‐chain factor XII exhibits activity when complexed to polyphosphate , 2014, Journal of thrombosis and haemostasis : JTH.

[8]  C. Longstaff,et al.  Regulation of fibrinolysis by C‐terminal lysines operates through plasminogen and plasmin but not tissue‐type plasminogen activator , 2012, Journal of thrombosis and haemostasis : JTH.

[9]  Stephanie A. Smith,et al.  Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation. , 2012, Blood.

[10]  A. Walch,et al.  Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo , 2012, The Journal of experimental medicine.

[11]  Krasimir Kolev,et al.  The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies , 2010, Blood.

[12]  C. Rienstra,et al.  Phosphoramidate end labeling of inorganic polyphosphates: facile manipulation of polyphosphate for investigating and modulating its biological activities. , 2010, Biochemistry.

[13]  H. Philippou,et al.  Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin. , 2010, Blood.

[14]  H. Lijnen,et al.  Fibrinolytic cross-talk: a new mechanism for plasmin formation. , 2010, Blood.

[15]  T. Renné,et al.  Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo , 2009, Cell.

[16]  Alberto Smith,et al.  Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis , 2009, Journal of vascular surgery.

[17]  James H Morrissey,et al.  Polyphosphate enhances fibrin clot structure. , 2007, Blood.

[18]  Alberto Smith,et al.  Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution. , 2006, Journal of vascular surgery.

[19]  James H Morrissey,et al.  Polyphosphate modulates blood coagulation and fibrinolysis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Oldfield,et al.  Human Platelet Dense Granules Contain Polyphosphate and Are Similar to Acidocalcisomes of Bacteria and Unicellular Eukaryotes* , 2004, Journal of Biological Chemistry.

[21]  A. Mondino,et al.  uPA and uPAR in fibrinolysis, immunity and pathology. , 2004, Trends in immunology.

[22]  W. Nieuwenhuizen,et al.  Molecular mechanisms of initiation of fibrinolysis by fibrin , 2003, Thrombosis and Haemostasis.

[23]  Alberto Smith,et al.  Failure of Thrombus to Resolve in Urokinase-Type Plasminogen Activator Gene-Knockout Mice: Rescue by Normal Bone Marrow-Derived Cells , 2003, Circulation.

[24]  F. Castellino,et al.  Critical role for conversion of glu-plasminogen to Lys-plasminogen for optimal stimulation of plasminogen activation on cell surfaces. , 2003, Trends in cardiovascular medicine.

[25]  C. Ponting,et al.  Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide. , 1998, The Biochemical journal.

[26]  R. Macko,et al.  Regression of proximal deep venous thrombosis is associated with fibrinolytic enhancement. , 1997, Journal of vascular surgery.

[27]  M. Nesheim,et al.  Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro. , 1992, The Journal of biological chemistry.

[28]  M. Meldal,et al.  The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation. , 1990, The Journal of biological chemistry.

[29]  G. Larsen,et al.  The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin. , 1990, The Journal of biological chemistry.

[30]  C. D. de Vries,et al.  Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin. , 1990, The Journal of biological chemistry.

[31]  W. Mangel,et al.  Characterization of an extremely large, ligand-induced conformational change in plasminogen. , 1990, Science.

[32]  F. Castellino,et al.  The reciprocal effects of epsilon-aminohexanoic acid and chloride ion on the activation of human [Glu1]plasminogen by human urokinase. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. V. van Zonneveld,et al.  On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid. , 1986, The Journal of biological chemistry.

[34]  A. Corti,et al.  Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[35]  F. Castellino.  Biochemistry of Human Plasminogen , 1984, Seminars in thrombosis and hemostasis.

[36]  M. Hoylaerts,et al.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. , 1982, The Journal of biological chemistry.

[37]  K. Robbins,et al.  Kinetics of activation of human plasminogen by different activator species at pH 7.4 and 37 degrees C. , 1980, The Journal of biological chemistry.

[38]  S. Thorsen,et al.  Rate of activation and electrophoretic mobility of unmodified and partially degraded plasminogen. Effects of 6-aminohexanoic acid and related compounds. , 1974, Scandinavian journal of clinical and laboratory investigation.

[39]  J. Vermylen,et al.  Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid. , 1974, Biochimica et biophysica acta.

[40]  B. Wiman,et al.  Studies on the conformational changes of plasminogen induced during activation to plasmin and by 6-aminohexanoic acid. , 1973, European journal of biochemistry.

[41]  K. Robbins,et al.  NH2-terminal sequences of mammalian plasminogens and plasmin S-carboxymethyl heavy (A) and light (B) chain derivatives. A re-evaluation of the mechanism of activation of plasminogen. , 1973, The Journal of biological chemistry.

[42]  T. Astrup,et al.  Fibrinogenolysis and Fibrinolysis with Tissue Plasminogen Activator, Urokinase, Streptokinase-Activated Human Globulin, and Plasmin 1 , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[43]  K. Robbins,et al.  The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin. , 1967, The Journal of biological chemistry.